FrancophonIA/ELRC3.0 huggingface dataset:
English: It is only indicated in the process of switching from Lixiana 30 mg (patients with one or more clinical factors for increased exposure; see table 1) to VKA, together with an appropriate VKA dose (see table 2, section 4.2).
Danish: Det er kun indiceret, når der skiftes fra Lixiana 30 mg (patienter med en eller flere kliniske faktorer for øget eksponering, se tabel 1) til VKA sammen med en passende VKA-dosis (se tabel 2, pkt.
English: If you currently take 30 mg (dose reduced) Lixiana:
Danish: Hvis du aktuelt tager 30 mg (dosisreduceret) Lixiana:
English: For transoesophageal echocardiogram (TEE) guided cardioversion in patients not previously treated with anticoagulants, Lixiana treatment should be started at least 2 hours before cardioversion to ensure adequate anticoagulation (see sections 5.1 and 5.2).
Danish: Ved transøsofageal ekkokardiogram (TEE)-styret kardiovertering hos patienter, der ikke i forvejen behandles med antikoagulanter, skal behandling med Lixiana påbegyndes mindst 2 timer før kardiovertering for at sikre tilstrækkelig antikoagulation (se pkt.
English: If a dose of Lixiana is missed, the dose should be taken immediately and then be continued the following day with the once-daily intake as recommended.
Danish: Hvis der glemmes en dosis af Lixiana, skal dosis straks tages, og den næste dag skal der fortsættes med den anbefalede indtagelse en gang dagligt.
English: Concomitant Lixiana and VKA can increase the INR post Lixiana dose by up to 46%.
Danish: Behandling med Lixiana sammen med VKA kan øge INR efter Lixiana-dosen med op til 46 %.
English: Lixiana is not recommended as an alternative to unfractionated heparin in patients with pulmonary embolism who are haemodynamically unstable or may receive thrombolysis or pulmonary embolectomy since the safety and efficacy of edoxaban have not been established in these clinical situations.
Danish: Lixiana bør ikke anvendes som alternativ til ufraktioneret heparin hos patienter med lungeemboli, som er hæmodynamisk ustabile, eller som evt. gennemgår trombolyse eller lungeembolektomi, da edoxabans sikkerhed og virkning ikke er blevet klarlagt i disse kliniske situationer.
English: If you currently take 60 mg Lixiana:
Danish: Hvis du aktuelt tager 60 mg Lixiana:
English: • For creatinine in mg/dL: (140-age [years]) × weight [kg] (× 0.85 if female) 72 × serum creatinine [mg/dL]
Danish: • For kreatinin i mg/dl: (140-alder [år]) × vægt [kg] (× 0,85 for kvinder) 72 × serumkreatinin [mg/dl]
English: Median [2.5 - 97.5% range] Prevention of stroke and systemic embolism: NVAF 30 mg QD ≥ 30 to ≤ 50
Danish: Median [2,5 - 97,5 % interval] Forebyggelse af apopleksi og systemisk emboli: NVAF 30 mg en gang dagligt
English: • Concomitant use of the following P-glycoprotein (P-gp) inhibitors: ciclosporin, dronedarone,
Danish: • Anvendelse sammen med følgende P-glykoprotein (P-gp)-hæmmere: ciclosporin, dronedaron,
English: In particular for patients that are triple positive (for lupus anticoagulant, anticardiolipin antibodies, and anti-beta 2glycoprotein I antibodies), treatment with DOACs could be associated with increased rates of recurrent thrombotic events compared with vitamin K antagonist therapy.
Danish: Navnlig for patienter, der er tredobbelt positive (for lupus antikoagulans, anticardiolipin-antistoffer og anti-beta 2-glykoprotein Iantistoffer), kan behandling med DOAK være forbundet med øget forekomst af recidiverende trombotiske hændelser i forhold til behandling med vitamin K-antagonister.
English: *Dose reduction to 30 mg for low body weight ≤ 60 kg or specific concomitant P-glycoprotein (P-gp) inhibitors
Danish: *Dosisreduktion til 30 mg for lav legemsvægt ≤ 60 kg eller specifik samtidig hæmning af Pglykoprotein (P-gp)
English: Table 10: Efficacy Results from the Hokusai-VTE Study - mITT population, overall study period
Danish: Tabel 10: Virkningsresultater fra Hokusai-VTE-studiet - mITT-population, samlet studieperiode Primære endepunkta
English: It is recommended that during the first 14 days of concomitant therapy the INR is measured at least 3 times just prior to taking the daily dose of Lixiana to minimise the influence of Lixiana on INR measurements.
Danish: Det anbefales at måle INR mindst 3 gange, lige før der tages den daglige dosis af Lixiana i løbet af de første 14 dages samtidig behandling for at minimere Lixianas påvirkning af INRmålingerne.
English: What you need to know before you take Lixiana 3.
Danish: Det skal du vide, før du begynder at tage Lixiana 3.
English: HR (95% CI) First SEE n (%/yr)a
Danish: HR (95 % CI) Første SEE n (%/år)a
English: • When an invasive procedure is required, Lixiana should be stopped at least 24 hours beforehand,
Danish: • Når det er nødvendigt med et invasivt indgreb, skal Lixiana stoppes mindst 24 timer i forvejen, og der skal tages passende hensyn.
English: Oral option: For patients currently on a 60 mg dose, administer a Lixiana dose of 30 mg once daily together with an appropriate VKA dose.
Danish: Oral mulighed: Til patienter, der aktuelt får en 60 mg dosis, administreres en Lixiana-dosis på 30 mg en gang dagligt sammen med en passende VKA-dosis.
English: Your doctor will decide if you should be treated with Lixiana and if you should be kept under observation.
Danish: Lægen vil beslutte, om du skal behandles med Lixiana, og om du skal holdes under observation.
English: A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from therapy.
Danish: Det skal besluttes, om amning skal ophøre eller behandling seponeres.
English: Prior to initiating Lixiana, liver function testing should be performed.
Danish: Før Lixiana påbegyndes, bør der udføres en leverfunktionsundersøgelse.
English: Taking an anticoagulant medicine such as Lixiana can increase your risk of bleeding.
Danish: Når du tager antikoagulerende medicin, såsom Lixiana, kan det øge din blødningsrisiko.
English: The edoxaban clinical programme for VTE was designed to demonstrate the efficacy and safety of edoxaban in the treatment of DVT and PE, and the prevention of recurrent DVT and PE.
Danish: Det kliniske edoxabanprogram ved venøs tromboembolisme (VTE) var designet til at påvise virkning og sikkerhed for edoxaban ved behandling af DVT og LE og til at forebygge recidiverende DVT og PE.
English: • other medicines to reduce blood clotting (e.g. heparin, clopidogrel or vitamin K antagonists such as warfarin, acenocoumarol, phenprocoumon or dabigatran, rivaroxaban, apixaban)
Danish: • andre lægemidler, der reducerer blodstørkningen (f.eks. heparin, clopidogrel eller K-vitaminantagonister, såsom warfarin, acenocoumarol, phenprocoumon eller dabigatran, rivaroxaban, apixaban)
English: Like other similar medicines (medicines to reduce blood clotting), Lixiana may cause bleeding which may potentially be life-threatening.
Danish: Lixiana kan som andre lignende lægemidler (lægemidler, der reducerer blodstørkningen) forårsage blødninger, som evt. kan være livstruende.
English: If you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk of blood clots), tell your doctor who will decide if the treatment may need to be changed.
Danish: Vær ekstra forsigtig med at tage Lixiana hvis du ved, at du har en sygdom, der hedder antifosfolipidsyndrom (en forstyrrelse i immunsystemet, der giver øget risiko for blodpropper), skal du sige det til lægen, som vil vurdere, om behandlingen skal ændres.
English: Lixiana should be restarted after the surgical or other procedures as soon as adequate haemostasis has been established, noting that the time to onset of the edoxaban anticoagulant therapeutic effect is 12 hours.
Danish: Behandlingen med Lixiana bør genoptages efter det kirurgiske indgreb eller andre procedurer, så snart der er opnået tilstrækkelig hæmostase, idet der tages hensyn til, at den antikoagulerende, terapeutiske virkning af edoxaban sætter ind efter 1 - 2 timer.
English: 1 Post-dose is equivalent to Cmax (post-dose samples were drawn 1 - 3 hours after edoxaban administration)
Danish: 1 Efter dosis svarer til Cmax (prøver efter dosis blev taget 1 - 3 timer efter administration af edoxaban) 2 Før dosis svarer til Cmin
English: Edoxaban 60 mg was non-inferior to warfarin for the primary efficacy endpoint of stroke or SEE (upper limit of the 97.5% CI of the HR was below the prespecified non-inferiority margin of 1.38) (Table 4).
Danish: Edoxaban 60 mg var non-inferior i forhold til warfarin for det primære endepunkt for virkning apopleksianfald eller SEE (øvre grænse for 97,5 % CI for HR var under den præspecificerede non-inferioritetsmargin på 1,38) (tabel 4).
English: The use of Lixiana with other P-gp inhibitors including HIV protease inhibitors has not been studied.
Danish: Anvendelsen af Lixiana sammen med andre P-gp-hæmmere, herunder hiv-proteasehæmmere, er ikke undersøgt.
English: Lixiana can be taken with or without food (see section 5.2).
Danish: Lixiana kan tages sammen med eller uden mad (se pkt.
English: Lixiana film-coated tablets edoxaban
Danish: Lixiana filmovertrukne tabletter edoxaban
English: Lixiana, like other anticoagulants, is recommended to be used with caution in patients with increased risk of bleeding.
Danish: Ligesom andre antikoagulantia bør Lixiana anvendes med forsigtighed hos patienter med en øget blødningsrisiko.
English: Anticoagulants: Co-administration of edoxaban with other anticoagulants is contraindicated due to increased risk of bleeding (see section 4.3).
Danish: Antikoagulantia: Administration af edoxaban sammen med andre antikoagulantia er kontraindiceret på grund af den forhøjede blødningsrisiko (se pkt.
English: Lixiana 15 mg is only to be used when changing from Lixiana 30 mg to a vitamin K antagonist (e.g. warfarin) (see section 3.
Danish: Lixiana 15 mg må kun anvendes ved skift fra Lixiana 30 mg til en K-vitaminagonist (f.eks. warfarin) (se pkt.
English: 30 mg and 60 mg film-coated tablets:
Danish: 30 mg og 60 mg filmovertrukne tabletter:
English: In Phase 3 clinical studies (both NVAF and VTE indications) patients with body weight ≤ 60 kg had a 50% edoxaban dose reduction and had similar efficacy and less bleeding when compared to warfarin.
Danish: I de kliniske studier i fase III (både for indikationerne NVAF og VTE) fik patienter med en legemsvægt ≤ 60 kg en 50 % dosisreduktion af edoxaban, og de havde sammenlignelige virkninger og mindre blødninger sammenlignet med warfarin.
English: Stop taking the vitamin K antagonist (e.g. warfarin).
Danish: Hold op med at tage K-vitaminantagonisten (f.eks. warfarin).
English: If you stop taking Lixiana
Danish: Hvis du holder op med at tage Lixiana
English: Lixiana 30 mg once daily must be administered during concomitant use with the following P-gp inhibitors:
Danish: Lixiana 30 mg en gang dagligt skal administreres ved samtidig anvendelse af følgende P-gphæmmere:
English: Edoxaban Anti-FXa activity post-dose (IU/mL)1
Danish: Edoxaban Anti-FXa-aktivitet efter dosis (IE/ml)1
English: The recommended dose is 60 mg edoxaban once daily.
Danish: Den anbefalede dosis er 60 mg edoxaban en gang dagligt.
English: Your doctor will need to do blood measurements and will instruct you when to stop taking Lixiana.
Danish: Det er nødvendigt for din læge at tage blodprøver og vil instruere dig i, hvornår du skal holde op med at tage Lixiana.
English: Lixiana is contraindicated in patients with hepatic disease associated with coagulopathy and clinically relevant bleeding risk (see section 4.3).
Danish: Lixiana er kontraindiceret hos patienter med leversygdom, der er forbundet med koagulopati og en klinisk relevant blødningsrisiko (se pkt.
English: If you forget to take Lixiana
Danish: Hvis du har glemt at tage Lixiana
English: The co-administration of Lixiana with ASA in elderly patients should be used cautiously because of a potentially higher bleeding risk (see section 4.5).
Danish: Administration af Lixiana sammen med ASA hos ældre patienter bør finde sted med forsigtighed på grund af en potentielt højere blødningsrisiko (se pkt.
English: Known complications secondary to severe bleeding such as compartment syndrome and renal failure due to hypoperfusion have been reported for Lixiana.
Danish: Der er for Lixiana indberettet kendte komplikationer sekundære til svær blødning som f.eks. kompartmentsyndrom og nyresvigt som følge af hypoperfusion.
English: Your doctor will need to do blood measurements and will instruct you when to start taking Lixiana.
Danish: Det er nødvendigt for din læge at tage blodprøver og vil instruere dig i, hvornår du skal begynde at tage Lixiana.
English: What Lixiana contains - The active substance is edoxaban (as tosilate).
Danish: Lixiana indeholder: - Aktivt stof: edoxaban (som tosilat).
English: This leaflet was last revised in {MM/YYYY}.
Danish: Denne indlægsseddel blev senest ændret {MM/ÅÅÅÅ} Andre informationskilder
English: 15 mg film-coated tablets:
Danish: 15 mg filmovertrukne tabletter:
English: Your doctor will tell you to reduce your dose of Lixiana to a 30 mg tablet once daily and to take it together with a vitamin K antagonist (e.g. warfarin).
Danish: Din læge vil fortælle dig, at du skal reducere din dosis af Lixiana til en tablet med 30 mg en gang dagligt og tage den sammen med en K-vitaminantagonist (f.eks. warfarin).
English: Prosthetic heart valves and moderate to severe mitral stenosis
Danish: Prostetiske hjerteklapper og moderat til svær mitralstenose.
English: Your doctor will tell you to reduce your dose of Lixiana to a 15 mg tablet once daily and to take it together with a vitamin K antagonist (e.g. warfarin).
Danish: Din læge vil fortælle dig, at du skal reducere din dosis af Lixiana til en tablet med 15 mg en gang dagligt og tage den sammen med en K-vitaminantagonist (f.eks. warfarin).
English: The concomitant use of edoxaban with other P-gp inducers (e.g. phenytoin, carbamazepine, phenobarbital or St. John's Wort) may lead to reduced edoxaban plasma concentrations.
Danish: Samtidig brug af edoxaban og andre P-gp-induktorer (f.eks. phenytoin, carbamazepin, phenobarbital eller prikbladet perikon) kan medføre et fald i edoxabans plasmakoncentrationer.
English: Switching to and from Lixiana
Danish: Skift til og fra Lixiana
English: Edoxaban Anti-FXa activity pre-dose (IU/mL)2
Danish: Edoxaban Anti-FXa-aktivitet før dosis (IE/ml)2
English: Driving and using machines Lixiana has no or negligible effects on your ability to drive or use machines.
Danish: Trafik- og arbejdssikkerhed Lixiana påvirker ikke eller kun i ubetydelig grad evnen til at føre motorkøretøj eller betjene maskiner.
English: 60 mg once daily Dose recommendation for patients with one or more of the following clinical factors: Renal Impairment
Danish: 60 mg en gang dagligt Dosisanbefaling for patienter med en eller flere af følgende kliniske faktorer:
English: Therefore Lixiana is contraindicated during breast-feeding (see section 4.3).
Danish: Derfor er Lixiana kontraindiceret til ammende kvinder (se pkt.
English: HR (95% CI) p-value
Danish: HR (95 % CI) p-værdi
English: How to take Lixiana).
Danish: Sådan skal du tage Lixiana).
English: Treatment of DVT, treatment of PE and the prevention of recurrent DVT and PE (VTE)
Danish: Behandling af DVT, behandling af PE og forebyggelsen af recidiverende DVT og PE (VTE)
English: Changing from Lixiana to non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban)
Danish: Skift fra Lixiana til non-VKA orale antikoagulantia (dabigatran, rivaroxaban eller apixaban)
English: Concomitant use of Lixiana with P-glycoprotein (P-gp) inhibitors
Danish: Samtidig anvendelse af Lixiana og hæmmere af P-glykoprotein (P-gp)
English: In patients concomitantly taking Lixiana and the following P-gp inhibitors: ciclosporin, dronedarone, erythromycin, or ketoconazole, the recommended dose is 30 mg Lixiana once daily (see section 4.5).
Danish: Hos patienter, der samtidigt tager Lixiana og følgende P-gp-hæmmere: ciclosporin, dronedaron, erythromycin eller ketoconazol, er den anbefalede dosis 30 mg Lixiana en gang dagligt (se pkt.
English: • Renal function should be assessed in all patients by calculating the creatinine clearance (CrCL) prior to initiation of treatment with Lixiana to exclude patients with end stage renal disease (i.e. CrCL < 15 mL/min), to use the correct Lixiana dose in patients with CrCL 15 - 50 mL/min (30 mg once daily), in patients with CrCL > 50 mL/min (60 mg once daily) and when deciding on the use of Lixiana in patients with increased creatinine clearance (see section 4.4).
Danish: • Nyrefunktionen skal vurderes hos alle patienter ved at beregne kreatininclearance (CrCl), før behandlingen med Lixiana påbegyndes, for at ekskludere patienter med nyresygdom i slutstadiet (dvs. CrCl < 15 ml/min.
English: Discontinue dabigatran, rivaroxaban or apixaban and start Lixiana at the time of the next dose of the oral anticoagulant (see section 5.1).
Danish: Seponer dabigatran, rivaroxaban eller apixaban, og start behandling med Lixiana på tidspunktet for den næste dosis af oral antikoagulation (se pkt.
English: Changing from non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban) to Lixiana
Danish: Skift fra non-VKA orale antikoagulantia (dabigatran, rivaroxaban eller apixaban) til Lixiana
English: Stop taking the previous medicines (e.g. dabigatran, rivaroxaban, or apixaban) and start Lixiana at the time of the next scheduled dose.
Danish: Hold op med at tage tidligere lægemidler (f.eks. dabigatran, rivaroxaban eller apixaban), og begynd med at tage Lixiana på tidspunktet for den næste planlagte dosis.
English: What you need to know before you take Lixiana
Danish: Det skal du vide, før du begynder at tage Lixiana
English: Switching to Lixiana
Danish: Skift til Lixiana
English: The method used to estimate renal function (CrCL in mL/min) during the clinical development of Lixiana was the Cockcroft-Gault method.
Danish: i løbet af den kliniske udvikling af Lixiana var Cockcroft-Gault-metoden.
English: INFORMATION IN BRAILLE Lixiana 60 mg
Danish: INFORMATION I BRAILLESKRIFT Lixiana 60 mg
English: Changing from Lixiana to parenteral anticoagulants (e.g. heparin)
Danish: Skift fra Lixiana til parenteral antikoagulation (f.eks. heparin)
English: INFORMATION IN BRAILLE Lixiana 15 mg
Danish: INFORMATION I BRAILLESKRIFT Lixiana 15 mg
English: Primary endpointa
Danish: Primære endepunkt
English: Changing from vitamin K antagonists (e.g. warfarin) to Lixiana
Danish: Ændring fra K-vitaminantagonister (f.eks. warfarin) til Lixiana
English: Therefore Lixiana should be used with caution in this population (see sections 4.4 and 5.2).
Danish: Derfor bør Lixiana anvendes med forsigtighed hos denne population (se pkt.
English: For patients with body weight ≤ 60 kg, the recommended dose is 30 mg Lixiana once daily (see section 5.2).
Danish: For patienter med en legemsvægt på ≤ 60 kg er den anbefalede dosis 30 mg Lixiana en gang dagligt (se pkt.
English: In patients with end stage renal disease or on dialysis, Lixiana is not recommended (see sections 4.2 and 5.2).
Danish: Hos patienter med nyresygdom i slutstadiet eller i dialyse bør Lixiana ikke anvendes (se pkt.
English: Stop taking Lixiana and start the non-VKA anticoagulant (e.g. dabigatran, rivaroxaban, or apixaban) at the time of the next scheduled dose of Lixiana.
Danish: Hold op med at tage Lixiana, og start non-VKA antikoagulation (f.eks. dabigatran, rivaroxaban eller apixaban) på tidspunktet for den næste planlagte dosis Lixiana.
English: INFORMATION IN BRAILLE Lixiana 30 mg
Danish: INFORMATION I BRAILLESKRIFT Lixiana 30 mg
English: Lixiana 60 mg once daily is recommended during concomitant use with the following P-gp inhibitors:
Danish: Lixiana 60 mg en gang dagligt bør administreres ved samtidig anvendelse af følgende P-gp-hæmmere:
English: First Ischaemic Stroke n
Danish: Første iskæmiske apopleksianfald N
English: Switching from Lixiana
Danish: Skift fra Lixiana
English: Changing from Lixiana to vitamin K antagonists (e.g. warfarin)
Danish: Skift fra Lixiana til K-vitaminantagonister (f.eks. warfarin)
English: Changing from parenteral anticoagulants (e.g. heparin) to Lixiana
Danish: Ændring fra parenteral antikoagulation (f.eks. heparin) til Lixiana
English: MARKETING AUTHORISATION NUMBER(S) EU/1/15/993/001 10 film-coated tablets EU/1/15/993/016 10 x 1 film-coated tablets
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/15/993/001 10 filmovertrukne tabletter EU/1/15/993/016 10 x 1 filmovertrukne tabletter
English: • Coagulation tests such as INR, prothrombin time (PT), or activated partial thromboplastin time (aPTT) are not a useful measure of the effect of Lixiana.
Danish: • Koagulationstests, såsom INR, protrombintid (PT) eller aktiveret partiel tromboplastintid (aPTT),
English: Parenteral option: Discontinue Lixiana and administer a parenteral anticoagulant and VKA at the time of the next scheduled Lixiana dose.
Danish: Parenteral mulighed: Seponer Lixiana, og administrer parenteral antikoagulation og VKA på tidspunktet for den næste planlagte Lixianadosis.
English: Moderate or severe (CrCL 15 - 50 mL/min)
Danish: Nedsat nyrefunktion Moderat eller svært (CrCl 15 - 50 ml/min.)
English: In patients with mild to moderate hepatic impairment the recommended dose is 60 mg Lixiana once daily (see section 5.2).
Danish: Hos patienter med let til moderat nedsat leverfunktion er den anbefalede dosis 60 mg Lixiana en gang dagligt (se pkt.
English: Event Rate (%/yr)b
Danish: Hændelsesrate (%/år)b
English: Macroscopic haematuria/urethral haemorrhage
Danish: Nyrer og urinveje Makroskopisk hæmaturi/uretral blødning
English: MARKETING AUTHORISATION NUMBER(S) 15 mg film-coated tablets: EU/1/15/993/001, EU/1/15/993/016 30 mg film-coated tablets: EU/1/15/993/002, EU/1/15/993/004-015 60 mg film-coated tablets: EU/1/15/993/003, EU/1/15/993/017-028
Danish: 30 mg filmovertrukne tabletter: EU/1/15/993/002, EU/1/15/993/004-015 60 mg filmovertrukne tabletter: EU/1/15/993/003, EU/1/15/993/017-028
English: Stop taking Lixiana and start the parenteral anticoagulant (e.g. heparin) at the time of the next scheduled dose of Lixiana.
Danish: Hold op med at tage Lixiana, og start parenteral antikoagulation (f.eks. heparin) på tidspunktet for den næste planlagte dosis Lixiana.
English: EU/1/15/993/025 100 film-coated tablets EU/1/15/993/026 10 x 1 film-coated tablets EU/1/15/993/027 50 x 1 film-coated tablets EU/1/15/993/028 100 x1 film-coated tablets
Danish: EU/1/15/993/025 100 filmovertrukne tabletter EU/1/15/993/026 10 x 1 filmovertrukne tabletter EU/1/15/993/027 50 x 1 filmovertrukne tabletter EU/1/15/993/028 100 x 1 filmovertrukne tabletter
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Danish: Brug af anden medicin sammen med Lixiana Fortæl det til lægen eller apotekspersonalet, hvis du tager anden medicin eller har gjort det for nylig.
English: Stop taking the anticoagulant (e.g. heparin) and start Lixiana at the time of the next scheduled anticoagulant dose.
Danish: Hold op med at tage antikoagulantia (f.eks. heparin), og start behandling med Lixiana på tidspunktet for den næste planlagte antikoagulantia-dosis.
English: Treatment of DVT, treatment of PE and prevention of recurrent DVT and PE (VTE)
Danish: Behandling af DVT, behandling af LE og forebyggelse af tilbagevendende DVT og LE (VTE)
English: EU/1/15/993/012 100 film-coated tablets EU/1/15/993/013 10 x 1 film-coated tablets EU/1/15/993/014 50 x 1 film-coated tablets EU/1/15/993/015 100 x1 film-coated tablets
Danish: EU/1/15/993/012 100 filmovertrukne tabletter EU/1/15/993/013 10 x 1 filmovertrukne tabletter EU/1/15/993/014 50 x 1 filmovertrukne tabletter EU/1/15/993/015 100 x 1 filmovertrukne tabletter
English: Discontinue Lixiana and start the non-VKA anticoagulant at the time of the next scheduled dose of Lixiana.
Danish: Seponer Lixiana, og start non-VKAantikoagulation på tidspunktet for den næste planlagte dosis Lixiana.
English: • problems with the blood vessels in your brain or spinal column if you have a mechanical heart valve
Danish: • problemer med blodårerne i hjerne eller rygsøjle
English: Lixiana should be used with caution in patients with mild to moderate hepatic impairment (see section 4.4).
Danish: Lixiana bør anvendes med forsigtighed hos patienter med let til moderat nedsat leverfunktion (se pkt.
English: How to take Lixiana
Danish: Sådan skal du tage Lixiana